Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
29 October 2024
Dear Shareholder,
Annual General Meeting – Letter to Shareholders
ClearVue Technologies Limited (ASX: CPV OTC:CVUEF) (“ClearVue" or the “Company”) advises that its
2024 Annual General Meeting (“AGM”) will be held at 11:00AM (AWST) on Friday, 29 November 2024 at
The Great Southern Room, State Library of WA, 25 Francis St, Perth WA 6000.
In accordance with Part 1.2AA of the Corporations Act 2001, the Company will only be dispatching physical
copies of the Notice of Meeting (“Notice”) to Shareholders who have elected to receive the Notice in
physical form. The Notice is being made available to Shareholders electronically and can be viewed and
downloaded online from the Company’s website at: https://www.clearvuepv.com/for-investors/.
Your vote is important
The business of the AGM affects your shareholding and your vote is important.
To vote in person, attend the AGM on the date and at the place set out above.
To vote by proxy please use one of the following methods:
Online
Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by following the
instructions: Log into the Automic website using the holding details as shown on the Proxy
Form. Click on ‘View Meetings’ – ‘Vote’. To use the online lodgement facility, Shareholders
will need their holder number (Securityholder Reference Number (SRN) or Holder
Identification Number (HIN)) as shown on the front of the Proxy Form.
By
post
Completing the enclosed Proxy Form and posting it to:
By
hand
Completing the enclosed Proxy Form and delivering it by hand to:
By
email
Completing the enclosed Proxy Form and emailing it to:
Automic, GPO Box 5193, Sydney NSW 2001
Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
meetings@automicgroup.com.au
Your Proxy instruction must be received not later than 48 hours before the commencement of the
Meeting. Proxy Forms received later than this time will be invalid.
1
Suite 7 / 567 Newcastle Street, West Perth, Western Australia 6005
P: +61 8 9220 9020
F: +61 8 9220 9029
E: hello@clearvuepv.com
W: www.clearvuepv.com
The Notice is important and should be read in its entirety. If you are in doubt as to the course of action
you should follow, you should consult your financial advisor, lawyer, accountant, or other professional
adviser.
The Chair intends to vote all open proxies in favour of all resolutions, where permitted.
Yours Faithfully,
Harry Miller
Company Secretary
2
CLEARVUE TECHNOLOGIES LIMITED
ACN 071 397 487
NOTICE OF ANNUAL GENERAL MEETING
Notice is given that the Meeting will be held at:
TIME:
11:00am (WST)
DATE:
29 November 2024
PLACE:
The Great Southern Room, State Library of WA
25 Francis St, Perth WA 6000
The business of the Meeting affects your shareholding and your vote is important.
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote,
they should seek advice from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at
4:00pm (WST) on 27 November 2024
BUSINESS OF THE MEETING
AGENDA
1.
FINANCIAL STATEMENTS AND REPORTS
To receive and consider the annual financial report of the Company for the financial year
ended 30 June 2024 together with the declaration of the Directors, the Director’s report,
the Remuneration Report and the auditor’s report.
2.
RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as a non-binding resolution:
“That, for the purposes of section 250R(2) of the Corporations Act and for all other
purposes, approval is given for the adoption of the Remuneration Report as
contained in the Company’s annual financial report for the financial year ended 30
June 2024.”
Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.
3.
RESOLUTION 2 – RE-ELECTION OF DIRECTOR – GERD HOENICKE
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purpose of clause 14.2 of the Constitution, Listing Rule 14.5 and for all
other purposes, Gerd Hoenicke, a Director, retires by rotation, and being eligible, is
re-elected as a Director.”
4.
RESOLUTION 3 – RATIFICATION OF PRIOR ISSUE OF CONSULTANCY SHARES
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 36,831 Shares to Deutsche Gesellschaft für Wertpapiersanalyse
GMBH on the terms and conditions set out in the Explanatory Statement.”
5.
RESOLUTION 4 – APPROVAL OF 7.1A MANDATE
To consider and, if thought fit, to pass the following resolution as a special resolution:
“That, for the purposes of Listing Rule 7.1A and for all other purposes, approval is
given for the Company to issue up to that number of Equity Securities equal to 10%
of the issued capital of the Company at the time of issue, calculated in accordance
with the formula prescribed in Listing Rule 7.1A.2 and otherwise on the terms and
conditions set out in the Explanatory Statement.”
6.
RESOLUTION 5 – ADOPTION OF EMPLOYEE INCENTIVE SECURITIES PLAN
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.2 (Exception 13(b)) and for all other purposes,
approval is given for the Company to issue up to maximum of 15,000,000 Securities
under the employee incentive scheme titled Employee Incentive Securities Plan, on
the terms and conditions set out in the Explanatory Statement.”
2
7.
RESOLUTION 6 – REPLACEMENT OF CONSTITUTION
To consider and, if thought fit, to pass the following resolution as a special resolution:
“That, for the purposes of section 136(2) and section 648G of the Corporations Act
and for all other purposes, approval is given for the Company to repeal its existing
Constitution and adopt a new constitution in its place in the form as signed by the
chairman of the Meeting for identification purposes.”
3
Voting Prohibition Statements
Resolution 1 – Adoption of
Remuneration Report
Resolution 5 - Adoption of
Employee Incentive Securities
Plan
A vote on this Resolution must not be cast (in any capacity) by or on behalf of
either of the following persons:
(a)
a member of the Key Management Personnel, details of whose
remuneration are included in the Remuneration Report; or
(b)
a Closely Related Party of such a member.
However, a person (the voter) described above may cast a vote on this
Resolution as a proxy if the vote is not cast on behalf of a person described
above and either:
(a)
the voter is appointed as a proxy by writing that specifies the way the
proxy is to vote on this Resolution; or
(b)
the voter is the Chair and the appointment of the Chair as proxy:
(i)
does not specify the way the proxy is to vote on this
Resolution; and
(ii)
expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly
with the remuneration of a member of the Key
Management Personnel.
A person appointed as a proxy must not vote, on the basis of that appointment,
on this Resolution if:
(a)
the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b)
the appointment does not specify the way the proxy is to vote on this
Resolution.
However, the above prohibition does not apply if:
(a)
the proxy is the Chair; and
(b)
the appointment expressly authorises the Chair to exercise the proxy
even though this Resolution is connected directly or indirectly with
remuneration of a member of the Key Management Personnel.
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the
Resolution set out below by or on behalf of the following persons:
Resolution 3 – Ratification of
Prior Issue of Consultancy
Shares
Resolution 5 – Adoption of
Employee Incentive Securities
Plan
Deutsche Gesellschaft für Wertpapiersanalyse GMBH or any other person who
participated in the issue or an associate of that person or those persons.
A person who is eligible to participate in the employee incentive scheme or an
associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in
that way; or
(b)
the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair
decides; or
(c)
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an associate of a person excluded from
voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in
accordance with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
•
each Shareholder has a right to appoint a proxy;
•
the proxy need not be a Shareholder of the Company; and
4
•
a Shareholder who is entitled to cast two or more votes may appoint two proxies and may
specify the proportion or number of votes each proxy is appointed to exercise. If the
Shareholder appoints two proxies and the appointment does not specify the proportion or
number of the member’s votes, then in accordance with section 249X(3) of the
Corporations Act, each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
•
if proxy holders vote, they must cast all directed proxies as directed; and
•
any directed proxies which are not voted will automatically default to the Chair, who must
vote the proxies as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
You may still attend the Meeting and vote in person even if you have appointed a proxy. If you
have previously submitted a Proxy Form, your attendance will not revoke your proxy appointment
unless you actually vote at the Meeting for which the proxy is proposed to be used, in which case,
the proxy’s appointment is deemed to be revoked with respect to voting on that Resolution.
Please bring your personalised Proxy Form with you as it will help you to register your attendance at
the Meeting. If you do not bring your Proxy Form with you, you can still attend the Meeting but
representatives from Automic Registry Services will need to verify your identity. You can register from
10.45am on the day of the Meeting.
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 8 7129 0437.
5
EXPLANATORY STATEMENT
This Explanatory Statement has been prepared to provide information which the Directors believe
to be material to Shareholders in deciding whether or not to pass the Resolutions.
1.
FINANCIAL STATEMENTS AND REPORTS
In accordance with the Corporations Act, the business of the Meeting will include receipt
and consideration of the annual financial report of the Company for the financial year
ended 30 June 2024 together with the declaration of the Directors, the Directors’ report,
the Remuneration Report and the auditor’s report.
The Company will not provide a hard copy of the Company’s annual financial report to
Shareholders unless specifically requested to do so. The Company’s annual financial report
is available on its website at www.clearvuepv.com.
2.
RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
2.1
General
The Corporations Act requires that at a listed company’s annual general meeting, a
resolution that the remuneration report to be adopted must be put to the shareholders.
However, such a resolution is advisory only and does not bind the company or the directors
of the company.
The remuneration report sets out the company’s remuneration arrangements for the
directors and senior management of the company. The remuneration report is part of the
directors’ report contained in the annual financial report of the company for a financial
year.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask
questions about or make comments on the remuneration report at the annual general
meeting.
2.2
Voting consequences
A company is required to put to its shareholders a resolution proposing the calling of
another meeting of shareholders to consider the appointment of directors of the company
(Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast
on a remuneration report resolution are voted against adoption of the remuneration report
and at the first of those annual general meetings a Spill Resolution was not put to vote. If
required, the Spill Resolution must be put to vote at the second of those annual general
meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must
convene a shareholder meeting (Spill Meeting) within 90 days of the second annual
general meeting.
All of the directors of the company who were in office when the directors' report (as
included in the company’s annual financial report for the most recent financial year) was
approved, other than the managing director of the company, will cease to hold office
immediately before the end of the Spill Meeting but may stand for re-election at the Spill
Meeting.
Following the Spill Meeting those persons whose election or re-election as directors of the
company is approved will be the directors of the company.
2.3
Previous voting results
At the Company’s previous annual general meeting the votes cast against the
remuneration report considered at that annual general meeting were less than 25%.
Accordingly, the Spill Resolution is not relevant for this Meeting.
6
3.
RESOLUTION 2 – RE-ELECTION OF DIRECTOR – GERD HOENICKE
3.1
General
Listing Rule 14.5 provides that an entity which has directors must hold an election of
directors at each annual general meeting.
The Constitution sets out the requirements for determining which Directors are to retire by
rotation at an annual general meeting.
Gerd Hoenicke, who has held office without re-election since 30 November 2023 and
being eligible retires by rotation and seeks re-election.
Further information in relation Gerd Hoenicke is set out below.
3.2
Qualifications,
experience and
other material
directorships
Mr Hoenicke is a recognised industry leader in facades and
curtain wall systems – a senior level executive with more than 35
years of progressively responsible experience in the international
facade industry. Mr Hoenicke has served as CEO of Gebrüder
Schneider GmbH, a German facade contractor before he joined
Seele GmbH in 2009 as its Technical Director. He has also served
as Director - Consulting International Projects for Schüco
International KG. Mr Hoenicke currently operates an
independent building envelope consultancy that engages with
architects and façade engineers on large construction projects
in the US and Europe. Mr Hoenicke’s impressive project portfolio
includes the German Chancellery building in Berlin, Central St.
Giles in London, EZB in Frankfurt, the Kimbell Art Museum in Dallas,
5 Broadgate in London and The Broad Museum in Los Angeles.
Each of these and many other projects reflect his attention to
detail in facade design and innovation. In 2019 Mr Hoenicke
established his own facade consultancy business and where he
has continued to be involved in various prestigious projects in the
US and the UK including recently Parcel 9 in Washington DC and
Landmark Pinnacle London.
Term of office
Gerd Hoenicke has served as a Director since 1 May 2023 and
was elected on 30 November 2023.
Independence
If re-elected, the Board considers that Gerd Hoenicke will be an
independent Director.
Board
recommendation
Having received an acknowledgement from Gerd Hoenicke that
he will have sufficient time to fulfil his responsibilities as a Director
and having reviewed the performance of Mr Hoenicke since his
appointment to the Board and the skills, knowledge, experience
and capabilities required by the Board, the Directors (other than
Gerd Hoenicke) recommend that Shareholders vote in favour of
this Resolution.
Technical information required by Listing Rule 14.1A
If this Resolution is passed, Gerd Hoenicke will be re-elected to the Board as an
independent Director.
If this Resolution is not passed, Gerd Hoenicke will not continue in his role as an
independent Director. The Company may seek nominations or otherwise identify suitably
qualified candidates to join the Company. As an additional consequence, this may
detract from the Board and Company’s ability to execute on its strategic vision.
4.
RESOLUTION 3 – RATIFICATION OF PRIOR ISSUE OF CONSULTANCY SHARES
4.1
General
This Resolution seeks Shareholder ratification for the purposes of Listing Rule 7.4 for the issue
of 36,831 Shares to Deutsche Gesellschaft für Wertpapiersanalyse GMBH (DGWA) on 19
June 2024 in consideration for consulting services provided by DGWA.
7
The Shares were issued under a consulting and services agreement between the
Company and DGWA (Consultancy Agreement). The material terms of the Consultancy
Agreement are set out below:
Term
Initial period of twelve (12) months with ability to extend for
additional periods of twelve (12) months.
Services
DGWA agreed to provide the Company with business
development, investor awareness and media dissemination
services.
Fees
The Company must pay to DGWA a fee of $5,000 per month,
payable 50% in cash and 50% in Shares (on a quarterly basis)
based on the 15-day volume weighted average price of the
Shares over the 15 trading days immediately prior to the start of
each quarter.
The Consultancy Agreement otherwise contains terms and conditions standard for an
agreement of its nature.
4.2
Listing Rule 7.1
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount
of equity securities that a listed company can issue without the approval of its shareholders
over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the
start of that 12 month period.
The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has
not yet been approved by Shareholders, it effectively uses up part of the 15% limit in Listing
Rule 7.1, reducing the Company’s capacity to issue further equity securities without
Shareholder approval under Listing Rule 7.1 for the 12 month period following the date of
the issue.
4.3
Listing Rule 7.4
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity
securities after it has been made or agreed to be made. If they do, the issue is taken to
have been approved under Listing Rule 7.1 and so does not reduce the company’s
capacity to issue further equity securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity
securities in the future without having to obtain Shareholder approval for such issues under
Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to
Listing Rule 7.4 for the issue.
4.4
Technical information required by Listing Rule 14.1A
If this Resolution is passed, the issue will be excluded in calculating the Company’s 15% limit
in Listing Rule 7.1, effectively increasing the number of equity securities the Company can
issue without Shareholder approval over the 12 month period following the date of the
issue.
If this Resolution is not passed, the issue will be included in calculating the Company’s 15%
limit in Listing Rule 7.1, effectively decreasing the number of equity securities that the
Company can issue without Shareholder approval over the 12 month period following the
date of the issue.
4.5
Technical information required by Listing Rules 7.4 and 7.5
REQUIRED INFORMATION
Names of persons to whom
Securities were issued or the
basis on which those
persons were
identified/selected
DETAILS
DGWA.
The Company confirms that no Material Persons were
issued more than 1% of the issued capital of the
Company.
8
REQUIRED INFORMATION
DETAILS
Number and class of
Securities issued
36,831 Shares were issued.
Terms of Securities
The Shares were fully paid ordinary shares in the capital
of the Company issued on the same terms and
conditions as the Company’s existing Shares.
Date(s) on or by which the
Securities were issued.
19 June 2024.
Price or other consideration
the Company received for
the Securities
Nil issue price per Share, issued pursuant to Listing Rule
7.1.
Purpose of the issue,
including the intended use
of any funds raised by the
issue
The Shares were issued at a nil issue price, in
consideration for consultancy services provided by
DGWA.
Summary of material terms
of agreement to issue
The Securities were issued under the Consultancy
Agreement, a summary of the material terms of which is
set out in Section 4.1.
Voting Exclusion Statement
A voting exclusion statement applies to this Resolution.
Compliance
The issue did not breach Listing Rule 7.1.
5.
RESOLUTION 4 – APPROVAL OF 7.1A MANDATE
5.1
General
This Resolution seeks Shareholder approval by way of special resolution for the Company
to have the additional 10% placement capacity provided for in Listing Rule 7.1A to issue
Equity Securities without Shareholder approval.
A summary of Listing Rule 7.1 is set out in Section 4.2 above.
Under Listing Rule 7.1A, an Eligible Entity may seek shareholder approval by way of a
special resolution passed at its annual general meeting to increase this 15% limit by an
extra 10% to 25% (7.1A Mandate). The Company is an Eligible Entity.
5.2
Technical information required by Listing Rule 14.1A
For this Resolution to be passed, at least 75% of votes cast by Shareholders present and
eligible to vote at the Meeting must be cast in favour of the Resolution.
If this Resolution is passed, the Company will be able to issue Equity Securities up to the
combined 25% limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval.
If this Resolution is not passed, the Company will not be able to access the additional 10%
capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1A
and will remain subject to the 15% limit on issuing Equity Securities without Shareholder
approval set out in Listing Rule 7.1.
5.3
Technical information required by Listing Rule 7.3A
REQUIRED
INFORMATION
Period for
which the 7.1A
Mandate is
valid
DETAILS
The 7.1A Mandate will commence on the date of the Meeting and
expire on the first to occur of the following:
(a)
the date that is 12 months after the date of this Meeting;
(b)
the time and date of the Company’s next annual general
meeting; and
9
REQUIRED
INFORMATION
DETAILS
(c)
Minimum price
Use of funds
the time and date of approval by Shareholders of any
transaction under Listing Rule 11.1.2 (a significant change in
the nature or scale of activities) or Listing Rule 11.2 (disposal
of the main undertaking).
Any Equity Securities issued under the 7.1A Mandate must be in an
existing quoted class of Equity Securities and be issued for cash
consideration at a minimum price of 75% of the volume weighted
average price of Equity Securities in that class, calculated over the 15
trading days on which trades in that class were recorded immediately
before:
(a)
the date on which the price at which the Equity Securities are
to be issued is agreed by the entity and the recipient of the
Equity Securities; or
(b)
if the Equity Securities are not issued within 10 trading days of
the date in paragraph (a) above, the date on which the
Equity Securities are issued.
The Company intends to use funds raised from issues of Equity
Securities under the 7.1A Mandate towards its expansion activities in
key global markets including the US (including for infrastructure and
additional staff in the US), systems and inventory to support global
sales, targeted IP or corporate acquisitions as well as the continued
development of the Company’s solar glass technology and BIPV
solutions, other sales and marketing expenses, general operational
expenses and working capital.
Risk of
economic and
voting dilution
Dilution
Issue Price
Number of Shares on
Issue (Variable A in
Listing Rule 7.1A.2)
Shares
issued –
10%
voting
dilution
$0.20
$0.40
$0.60
50%
decrease
Issue Price
50%
increase
Funds Raised
Current
243,283,474
Shares
24,328,347
Shares
$4,865,669
$9,731,338
$14,597,008
50%
increase
364,925,211
Shares
36,492,521
Shares
$7,298,504
$14,597,008
$21,895,513
100%
increase
486,566,948
Shares
48,656,694
Shares
$9,731,338
$19,462,677
$29,194,016
Any issue of Equity Securities under the 7.1A Mandate will dilute the
interests of Shareholders who do not receive any Shares under the
issue.
If this Resolution is approved by Shareholders and the Company issues
the maximum number of Equity Securities available under the 7.1A
Mandate, the economic and voting dilution of existing Shares would
be as shown in the table below.
The table below shows the dilution of existing Shareholders calculated
in accordance with the formula outlined in Listing Rule 7.1A.2, on the
basis of the closing market price of Shares and the number of Equity
Securities on issue or proposed to be issued as at 14 October 2024.
The table also shows the voting dilution impact where the number of
Shares on issue (Variable A in the formula) changes and the economic
dilution where there are changes in the issue price of Shares issued
under the 7.1A Mandate.
10
REQUIRED
INFORMATION
DETAILS
*The number of Shares on issue (Variable A in the formula) could increase as a result
of the issue of Shares that do not require Shareholder approval (such as under a
pro-rata rights issue or scrip issued under a takeover offer) or that are issued with
Shareholder approval under Listing Rule 7.1.
The table above uses the following assumptions:
1.
There are currently 243,283,474 Shares on issue.
2.
The issue price set out above is the closing market price of the Shares on the
ASX on 14 October 2024 (being $0.40) (Issue Price). The Issue Price at a 50%
increase and 50% decrease are each rounded to three decimal places prior
to the calculation of the funds raised.
3.
The Company issues the maximum possible number of Equity Securities under
the 7.1A Mandate.
4.
The Company has not issued any Equity Securities in the 12 months prior to the
Meeting that were not issued under an exception in Listing Rule 7.2 or with
approval under Listing Rule 7.1.
5.
The issue of Equity Securities under the 7.1A Mandate consists only of Shares. It
is assumed that no Options are exercised into Shares before the date of issue
of the Equity Securities. If the issue of Equity Securities includes quoted Options,
it is assumed that those quoted Options are exercised into Shares for the
purpose of calculating the voting dilution effect on existing Shareholders.
6.
The calculations above do not show the dilution that any one particular
Shareholder will be subject to. All Shareholders should consider the dilution
caused to their own shareholding depending on their specific circumstances.
7.
This table does not set out any dilution pursuant to approvals under Listing Rule
7.1 unless otherwise disclosed.
8.
The 10% voting dilution reflects the aggregate percentage dilution against the
issued share capital at the time of issue. This is why the voting dilution is shown
in each example as 10%.
9.
The table does not show an example of dilution that may be caused to a
particular Shareholder by reason of placements under the 7.1A Mandate,
based on that Shareholder’s holding at the date of the Meeting.
Shareholders should note that there is a risk that:
Allocation
policy under
7.1A Mandate
(a)
the market price for the Company’s Shares may be
significantly lower on the issue date than on the date of the
Meeting; and
(b)
the Shares may be issued at a price that is at a discount to
the market price for those Shares on the date of issue.
The recipients of the Equity Securities to be issued under the 7.1A
Mandate have not yet been determined. However, the recipients of
Equity Securities could consist of current Shareholders or new investors
(or both), none of whom will be related parties of the Company.
The Company will determine the recipients at the time of the issue
under the 7.1A Mandate, having regard to the following factors:
(a)
the purpose of the issue;
(b)
alternative methods for raising funds available to the
Company at that time, including, but not limited to, an
entitlement issue, share purchase plan, placement or other
offer where existing Shareholders may participate;
(c)
the effect of the issue of the Equity Securities on the control
of the Company;
(d)
the circumstances of the Company, including, but not
limited to, the financial position and solvency of the
Company;
(e)
prevailing market conditions; and
(f)
advice from corporate, financial and broking advisers (if
applicable).
11
REQUIRED
INFORMATION
DETAILS
Previous
app
Share your feedback
Discover